INVICTA logo

Invicta Diagnostic Limited Stock Price

NSEI:INVICTA Community·₹980.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

INVICTA Share Price Performance

₹0
-96.70 (-100.00%)
₹0
-96.70 (-100.00%)
Price ₹0

INVICTA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks
2 Rewards

Invicta Diagnostic Limited Key Details

₹301.8m

Revenue

₹23.6m

Cost of Revenue

₹278.2m

Gross Profit

₹229.3m

Other Expenses

₹48.9m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
3.89
92.17%
16.21%
26.0%
View Full Analysis

About INVICTA

Founded
2016
Employees
105
CEO
Konica Srivastava
WebsiteView website
www.pcdiagnostics.in

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access modes for tests reports. It caters individual and institutional customers. The company was founded in 2016 and is based in Mumbai, India.

Recent INVICTA News & Updates

Recent updates

No updates